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Abstract
To facilitate the direct study of progenitor cell biology, we have
developed a simple and efficient procedure based upon negative
selection by panning to purify large numbers of committed ery-
throid and myeloid progenitors from human fetal liver. The non-
adherent, panned cells constitute a highly enriched population
of progenitor cells, containing 30.4±13.1% erythrocyte burst
forming units (BFU-E), 5.5±1.9% granulocyte-macrophage col-
ony forming units (CFU-GM), and 1.4±0.7% granulocyte-ery-
throid-macrophage-megakaryocyte colony forming units (CFU-
GEMM) as assayed in methylcellulose cultures. These cells are
morphologically immature blasts with prominent Golgi. This
preparative method recovers 60-100% of the committed pro-
genitors detectable in unfractionated fetal liver and yields 2-30
X 106 progenitors from each fetal liver sample, and thus provides
sufficient numbers of enriched progenitors to allow direct bio-
chemical and immunologic manipulation. Using this technique,
a purified recombinant protein previously thought to have only
granulocyte-macrophage colony stimulating activity (GM-CSA)
is shown to have both burst promoting activity and multipotential
colony stimulating activity. Progenitor purification by panning
thus appears to be a simple, efficient method that should facilitate
the direct study of committed hematopoietic progenitors and their
differentiation.
Introduction
The cellular and molecular analysis ofhematopoietic regulation
has been hindered by the extreme rarity of the critical hema-
topoietic progenitor cells in the bone marrow and peripheral
blood (1, 2, 3). Identification and accurate characterization of
colony stimulating activities have been particularly difficult due
to the endogenous production of these activities by accessory
cells that contaminate the progenitor cells isolated by current
techniques. Thus, a source of purified progenitors and purified
factors would be invaluable for the accurate analysis of hema-
topoietic regulation. Approaches to the purification of progenitor
cells have included differential density centrifugation (4) and
density gradient electrophoresis (5), immune selection using ro-
setting (6) or fluorescence-activated cell sorting (7, 8), and various
combinations of these physical and immunologic techniques (9).
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While these techniques have led to a significant progenitor en-
richment, cell yields have been notably low, particularly when
the prefractionation sample consists of normal, nonneoplastic
human hematopoietic cells. This limitation has restricted bio-
chemical analysis of the enriched progenitors, and has prevented
detailed studies of growth factor and accessory cell interactions
with human progenitor cells.
We have therefore developed a simple and efficient procedure
to purify large numbers of human erythroid and myeloid pro-
genitors. Beginning with fetal liver cells (10, 1 1, 12) and utilizing
negative selection by panning (13, 14, 15), the technique greatly
enriches the progenitor cells and provides, for the first time,
sufficient numbers of progenitors to allow direct morphological
and biochemical studies ofthese cells. In this report, we describe
this progenitor purification technique, we present preliminary
morphologic analysis of the progenitors, and we show that a
purified recombinant protein initially characterized as granu-
locyte-macrophage colony stimulating activity (GM-CSA) (16)
in fact possesses both burst promoting activity (BPA)' and mul-
tipotential colony stimulating activity (multi-CSA).
Methods
Isolation of mononuclear cells from fetal liver. Abortuses induced by
prostaglandin infusion were obtained within 30 min of delivery from
patients who had previously signed consent forms for research studies,
under a protocol approved by the Brigham and Women's Hospital Hu-
man Investigation Committee. Livers from 17- to 23-wk fetuses were
sterilely dissected and teased into Iscove's modified Dulbecco's medium
(IMDM) containing 50 mg% collagenase Type IV (Sigma Chemical Co.,
St. Louis, MO) using forceps and scissors. Hepatic stroma was digested
by incubating the collagenase-rich cell suspension at 370C under 5%
CO2 for 15-30 min (17) and large clumps were allowed to settle out by
standing the cell suspension in vertical 50-ml centrifuge tubes. A mono-
nuclear cell preparation was prepared by centrifugation over Ficoll Hy-
paque SG 1.077, through which sedimented mature blood cells and he-
patocytes. The cells at the interface were washed three times, and then
subjected to a second buoyant density separation over Ficoll Hypaque
SG 1.077. The cells at the interface were washed three times and then
depleted of adherent cells by overnight adherence to 100 X 15 mm plastic
tissue culture dishes (Lux, Miles Laboratories, Naperville, IL) in IMDM
with 20% fetal calf serum (FCS) at 370C under 5% CO2.
Immune depletion by adherence to anti-Ig coated plates (panning).
1. Abbreviations used in this paper: BPA, burst promoting activity; BFU-
E, erythrocyte burst forming units;CFU-GEMM, granulocyte-erythroid-
macrophage-megakaryocyte colony forming units; CFU-GM, granulo-
cyte-macrophage colony forming units; CSA, colony stimulating activity;
FCS, fetal calf serum; GM-CSA, granulocyte-macrophage colony stim-
ulating activity; GM-CSF, granulocyte-macrophage colony stimulating
factor; IMDM, Iscove's modified Dulbecco's medium; multi-CSA, mul-
tipotential colony stimulating activity.
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Nonadherent cells were incubated with saturating quantities of a panel
of eight murine monoclonal antibodies for I h at 40C. The antibodies,
their sources, specificities, and the quantities per 106 cells which were
employed were as follows: anti-Leu- 1 (Becton-Dickinson & Co., Oxnard,
CA), T cells, 100 ng; anti-leu Sb (Becton-Dickinson & Co.), T cells and
NK cells, 40 ng; anti-leu-l0 (Becton-Dickinson & Co.), HLA-DC, 400
ng; anti-leu-M 1 (Becton-Dickinson &Co.), mature and precursor myeloid
and monocytic cells, 200 ng; anti-BA-I (Hybritech, Inc., La Jolla, CA),
B cells, 200 ng; anti-CALLA (Hybritech), pre-B cells, 300 ng; TG- I (Peter
Beverley [7]), granulocytes, myeloid precursors, some monocytes, 5 ,1
hybridoma supernatant; R. 18.84 (Paul Edwards [18]) glycophorin A, 1
Ml hybridoma supernatant. Labeled cells were then washed three times
to remove excess antibody before panning. Preparative separation of
antibody-negative cells (panning) was performed by a modification of
the method of Biddison et al. (14). Anti-Ig plates were prepared by in-
cubating 100 X 15 mm plastic culture plates (Lux) with 5 ml affinity
purified rabbit anti-mouse Ig (100 jig/ml in phosphate-buffered saline
[PBS]) overnight at 4°C and washing with cold PBS before use. Coating
the plates with <250 Mg antibody resulted in suboptimal cell binding.
Murine antibody-labeled, washed cells were suspended in 5 ml PBS at
1-5 X 10' cells/ml with 5% heat-inactivated FCS and incubated over
the rabbit anti-mouse Ig coated plates for I h at 4°C, after which time
the nonadherent antibody negative cells were recovered by gentle pipetting
without disrupting the antibody-coated cells bound to the plates. Incu-
bation times of<40 min were ineffective at allowing maximal cell binding
to the plates, while cells could be allowed to adhere to the plates for at
least 2 h without decreased binding or subsequent plating efficiency.
Immunofluorescence staining. After immune depletion by panning,
the presence of residual hematopoietic precursor cells was assessed mor-
phologically and by indirect fluorescent labeling under three conditions:
(a) Cells were immediately relabeled with fluoresceinated goat anti-mouse
Ig to detect residual mouse antibody coated cells; (b) other aliquots of
cells were immediately relabeled with the individual murine monoclonal
antibodies, followed by fluoresceinated goat anti-mouse Ig to assay cells
that had been ineffectively labeled; and (c) a final aliquot was cultured
at 37°C for 4 h before relabeling, to identify cells that might have mod-
ulated surface antigens on exposure to the murine antibodies and so
escaped the secondary antibody-coated plates. Fluorescent antibody-
stained cells were quantitated by flow cytometric analysis (fluorescence
analyzer, Becton-Dickinson & Co.)
In vitro short-term cultures. Cells were cultured in 0.9% methyl cel-
lulose in IMDM plus 30% FCS, 0.9% deionized bovine serum albumin
(Fraction V; Sigma Chemical Co.), and 10 M-4 f-mercaptoethanol. To
measure erythrocyte burst forming unit (BFU-E) derived colonies the
cells were cultured in the presence of I u/ml erythropoietin (Terry Fox
Laboratories, Vancouver, British Columbia) (19). Granulocyte-macro-
phage colony forming units (CFU-GM) and granulocyte-erythroid-mac-
rophage-megakaryocyte colony forming units (CFU-GEMM) were as-
sayed by culturing the cells in the presence of 10% vol/vol Mo conditioned
medium as well. Red colonies (usually containing over 1,000 cells and
always at least 100 cells) present on day 14 were scored as BFU-E; colonies
containing nonhemoglobinized cells (primarily granulocytic precursors
and macrophages) were scored as CFU-GM, while colonies containing
both erythroid elements and one or more classes of phagocytic on mega-
karyocytic cells were scored asCFU-GEMM. Cultures were plated either
in quadruplicate 250-Ml volumes in 24-well tissue culture plates or in 10
replicates in 100-Mul volumes in 96-well plates (Falcon Labware, Becton-
Dickinson & Co.). The cultures were established at sufficiently low density
to clearly distinguish individual colonies, usually 5 X 104 cells/ml for
cells after one Ficoll gradient, 104 cells/ml for cells obtained after the
second gradient step and adherence depletion, and 103 cells/ml obtained
after depletion by panning. No filler cells or irradiated feeder cells were
added to the cultures. Progenitor recovery was measured by normalizing
the progenitor frequency assayed in each fraction by the percentage of
cells removed during the purification, taking the number of progenitors
present in the original ficoll interface mononuclear cell fraction as 100%:
% recovery = colonies per 105 cells x proportion of cells recovered
colonies per I O' cells in the unfractionated (Ficoll X 1) sample X 100.
Demonstration of GM-CSA, BPA, and multi-CSA. Recombinant
colony stimulating activity cloned and purified from the complementary
DNA (cDNA) of the Mo cell line was prepared as previously described
(16). Briefly, a cDNA library was derived from messenger RNA (mRNA)
of lectin-stimulated Mo cells, and active clones coding for colony stim-
ulating activity (CSA) were detected by transfection of monkey COS-I
cells. The recombinant CSA was then purified from serum-free COS-l
supernatants by gel filtration and high performance liquid chromatog-
raphy. GM-CSA, BPA, and multi-CSA were assayed on the final purified
progenitor fraction by initiating methylcellulose cultures in the presence
of graded concentrations of the HPLC purified recombinant protein,
and after 3 d I U/ml erythropoietin was added to each replicate (20,
21). No additional source of BPA or CSA was included in the cultures.
BFU-E, CFU-C, and CFU-GEMM were enumerated on day 14, as before.
Results
Cell recovery and analysis through the fractionation. The fetal
progenitor purification schema, with two ficoll gradients, one
adherence depletion, and a final immune depletion by panning,
is shown in Fig. 1. The first ficoll step removed the mature eryth-
rocytes, rare mature myeloid cells, and hepatocytes. The cells
at the interface were >95% mature erythroid precursors with
<5% myeloid and mononuclear precursors. The second ficoll
step further removed 70-90% of the cells, including >80% of
metamyelocytes, myelocytes, and orthrochromatophilic and
polychromatophilic normoblasts. The cells at the interface con-
sisted of 10-15% blasts, 20-30% promyelocytes, and 50-70%
basophilic and polychromatophilic normoblasts.
After adherence depletion, the remaining cells were labeled
with a panel of eight murine monoclonal antibodies including
at least two antibodies that detect each major class of leukocyte,
and antiglycophorin A to detect the predominant antigen on
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Figure 1. Purification of fetal progenitors by panning. Single cell sus-
pensions of fetal liver mononuclear cells were subjected to two se-
quential Ficoll gradients and adherence depletion, followed by anti-
body labeling and depletion of antibody-coated cells by panning. Pro-
genitor cells are depicted as open stars, nonprogenitor cells as closed
circles.
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Table I. Progressive Purification ofFetal Progenitors
CFU-GM CFU-GEMM
Fractionation step Cells recovered BFU-E colonies/105 cells Percent yield colonies/105 cells Percent yield colonies/105 cells Percent yield
Ficoll X 1 300-3,000 X 106 218±18* 100 87±8 100 11±2 100
Ficoll X 2, Ad- 30-600 X 106 2,200±340 95±3 950±82 97 + 2 120±2 97 + 2
Ficoll X 2, Ad-, Ab- 2-60 X 106 30,400±13,000 88 + 10 5,500±1,900 62 + 20 1,400±700 98 + 10
(Range, 18,000-55,000) (Range, 3,200-15,000) (Range, 500-2,800)
* Mean values±standard deviations from 12 experiments.
erythroid precursors. In preliminary experiments each antibody
was shown to bind to precursor cells and mature cells, without
detecting progenitor cells. The combined use of several overlap-
ping anti-leukocyte antibodies and a very potent anti-erythroid
antibody allowed for excellent cell depletion after a single 1-h
pan at 4VC. Under a variety of relabeling conditions, no more
than 2% of the remaining cells were stained with antibodies de-
tecting known hemato-lymphoid subsets. The single pan re-
moved 90-95% of the cells, and the remaining antibody-negative
cells were at least 97% viable by trypan blue exclusion.
Progressive purification of hematopoietic progenitors. This
sequential fractionation procedure resulted in marked enrich-
ment of the progenitor cells (Table I). The mononuclear cells
obtained after one Ficoll step contained -0.3% progenitors. Af-
ter the second gradient step and adherence depletion, over 3%
of the remaining cells scored as progenitors in vitro. After the
panning step, the progenitors were greatly enriched with 22-
75% ofthe cells scoring as progenitors in short-term culture. No
progenitors could be detected by culturing cells obtained from
either the Ficoll gradient pellets or the antibody-coated plates.
The majority of the progenitors present in the original fetal
liver mononuclear cell suspension were recovered throughout
the fractionation procedure. In the final fraction, after double
ficoll separation, adherence depletion and panning, 88±10% of
BFU-E, 62±20% of CFU-GM, and 98±10% of CFU-GEMM
were recovered. Thus, the 2-60 X 106 cells obtained from each
fractionation contained most of the progenitors present in the
original fetal liver.
Linear plating efficiency to low cell concentration. This high
degree ofprogenitor purity permitted short-term in vitro culture
at low cell density (Fig. 2). Cells obtained after the first ficoll
step were routinely cultured at 105 cells/ml, and could only be
diluted to 104 cells/ml while still retaining normal growth char-
acteristics. Below this concentration the colonies which began
to develop disintegrated a few days into the culture. Cells ob-
tained after a second gradient separation and adherence depletion
could be cultured over a range of from 103_-10 cells/ml with
linear plating characteristics.
The highly enriched progenitors isolated after panning could
be cultured at 102-104 cells/ml while maintaining qualitatively
normal colony growth and linear plating characteristics. When
cultured at higher density, the colonies overlapped in the plates
and could not be accurately enumerated. When the cells were
plated at <102/ml (10-25 cells per well), colony growth was
poor, with only small poorly differentiated colonies that disin-
tegrated prematurely.
Initial characterization ofthepurifiedprogenitors. Sufficient
quantities of purified progenitors were thus obtained to permit
direct morphological and histochemical characterization of these
cells. When stained with routine Wright-Giemsa, the cells ap-
peared to be undifferentiated blasts of variable size with baso-
philic cytoplasm, prominent Golgi zones, and often containing
multiple nucleoli. In addition, the cell membranes showed many
small areas of extrusion suggesting uropod formation (Fig. 3).
There were no detectable cells resembling small lymphocytes,
and as expected, only very rare contaminating recognizable ery-
throid or myeloid precursors were found. The panned progenitor
cells did not stain with standard histochemical dyes, including
myeloperoxidase, periodic acid-Schiff, nonspecific esterase, al-
kaline phosphatase, and acid phosphatase.
Detection of BPA and multi-CSA in recombinant protein.
These highly enriched progenitors were then used to detect the
range of myeloid stimulating activities present in a purified re-
combinant protein cloned from the Mo cell line (16), which was
initially thought to have only a restricted GM-CSA. Short-term
cultures were initiated in methylcellulose without erythropoietin,
which was added on day three. Under these conditions no col-
onies developed, as all of the accessory cells that contribute to
the survival and proliferation of the progenitor cells had been
removed and no exogenous source ofBPA or CSA (e.g. Mo CM)
had been added (Fig. 4). However, when the recombinant protein
was added at the initiation of the cultures, erythroid bursts and
mixed GEMM colonies as well as purely myeloid colonies were
detected. Maximal BPA was detectable with as little as 1 ng/ml
added recombinant protein, and both BPA and multi-CSA were
detectable with as little as 10 pg/ml. The use of purified progen-
itors depleted ofknown accessory cells thus results in extremely
low background that permits the detection of BPA and multi-
CSA in this protein.
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Figure 2. Linear plating efficiency of fetal liver progenitors. Cells ob-
tained from three stages of the purification (after the first Ficoll gra-
dient, after the second Ficoll gradient, and after the adherence pan-
ning depletion step) were plated in methyl cellulose at 102-I05 cells
per ml. The data are shown as total colonies (BFU-E + CFU-GM
+ CFJ-GEMM) per ml, and represent mean values from one of four
similar experiments. *, two Ficolls, nonadherent cells, antibody nega-
tive cells after panning; o, two Ficolls, nonadherent cells; o, one Ficoll.
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Figure 3. Wright-Giemsa stain of the panned progenitor cells. Note
the prominent Golgi, nucleoli, and membrane exfoliation. Colony fre-
quencies from this particular preparation were: BFU-E, 39%; CFU-
GM, 9.5%; CFU-GEMM, 1.5%.
Discussion
This technique provides a superior method for the isolation of
large numbers ofhighly enriched, relatively unmanipulated pro-
genitors. Of note, the calculated progenitor frequency of 22-
75% may be an underestimate of the actual number of progen-
itors present in the final fraction, due to the limitations of in
vitro culture per se. Visser et al. (22) have found that murine
progenitor cells which they calculate to be 100% in vivo primary
CFU-S have only a 25-30% plating efficiency in vitro. Ogawa
and his colleagues (23) have found that the replating efficiency
in methylcellulose of observable, dividing colony progenitors is
only 50-75%. Thus the actual frequency of progenitors in the
post-panning fraction may be closer to 50-100%, with the lower
observed frequency due to the imperfect plating efficiency of
the methyl cellulose system itself.
Panning for negative selection has several advantages over
other techniques for progenitor purification. Unlike rosetting (6,
24, 25) or complement mediated lysis, panning involves no po-
tential nonspecific toxins, such as CrCl3 or complement, which
can damage the progenitors. This is extremely important for
normal progenitors, which we have found are quite sensitive to
nonspecific damage by CrCl3-coupled erythrocytes used for ro-
setting, unlike leukemic progenitors, which may be somewhat
more resistant. Moreover, the panning procedure is based on
the labeling ofonly undesired cells, without direct manipulation
ofthe progenitors themselves. Thus, the in vitro behavior ofthe
recovered progenitors is unlikely to be artifactually influenced
by the antibody treatment per se. Finally, panning is very simple
10-8 10-6 10-410-2 1 102
CSA Final Concentration (nglmb)
Figure 4. Multipotential colony stimulating activity demonstrated us-
ing purified progenitor target cells. Purified progenitors were cultured
in methylcellulose in the presence ofgraded concentrations of purified
recombinant colony stimulating activity, with erythropoietin added on
day three. The data shown are mean±standard deviations from
quaruplicate samples and are from one of three similar experiments.
and easy to perform, and results in an extremely high yield of
recovered progenitors. In these respects it is superior to multi-
parameter fluorescence-activated cell sorting, for example, which
requires sophisticated equipment and still results in typical cell
yields of only 20-50%.
The isolated progenitors appear to be basophilic, undiffer-
entiated blasts with prominent Golgi zones and frequent mem-
branous extrusions. The active Golgi suggests that these cells
are actively synthesizing membrane glycoproteins, likely in-
cluding membrane receptors for hematopoietic growth factors.
Thus these cells might be an excellent cell population for iden-
tification and study ofsuch receptors. The unusual folded mem-
brane may reflect submembranous cytoskeletal structures re-
sponsible for the immature progenitors' motility, which are re-
sponsible for the multicentric nature of erythroid bursts and
multilineage colonies.
Ideally, one would like to be able to culture these progenitors
at limiting dilution to address directly questions such as the role
of soluble factors, and auxiliary cells in altering the stochastic
program ofdifferentiating progenitors. So far, however, we have
only succeeded in routinely culturing these cells at 100 cells/ml
(10-25 cells/well), despite trials of irradiated feeder layers, added
progenitor conditioned culture medium, and a variety ofadded
soluble factors. Whether fetal progenitors require a continuous
supply ofautocrine factors, have stringent buffering requirements
which we have not yet solved, or require an as yet unidentified
accessory cell to respond to the trophic effects of added soluble
CSAs, remains to be determined. If fetal progenitors do require
intermediary accessory cells to respond to added soluble factors,
however, their behavior would be quite different from that of
circulating adult BFU-E, which respond directly to BPA (25).
The high progenitor concentration and the lack of T cells,
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monocytes, and other cells known to produce hematopoietic
growth factors allow the purified progenitor pool to be an ex-
tremely sensitive and accurate test population for assaying the
activity of soluble factors and defined cell populations. In this
study these purified progenitors were used to demonstrate that
a purified recombinant protein previously thought to have only
limited GM-CSA in fact processes both BPA and multi-CSA.
Removing the active accessory cells was in fact essential to dem-
onstrating the full spectrum of activity of the recombinant CSA
molecule.
-Although this protein has -60% DNA sequence homology
with murine granulocyte-macrophage colony stimulating factor
(GM-CSF) and none with murine interleukin-3 (IL-3) (16), its
activity resembles that of murine IL-3. Inasmuch as no human
DNA sequences homologous to murine IL-3 have yet been de-
tected, it is possible that during evolution the human GM-CSA
gene has taken over the multipoietin role characteristic of IL-3
in the mouse. It will be of interest to determine, once their DNA
and protein sequences are known, whether molecules with pu-
tative multipotential CSA purified from other sources (26) are
identical to the protein analyzed in this study, and to measure
the full target cell specificities and phylogenetic ranges ofactivities
of these hormones.
This method for progenitor purification should prove to be
extremely valuable for the further study of the regulation of
hematopoiesis. The preparations provide, for the first time, suf-
ficient normal cells for the direct biochemical isolation ofhuman
progenitor membrane proteins, including membrane receptors
for such proteins as erythropoietin and multipotential CSA.
Similarly, the purified progenitors are an ideal immunogen and
screening cell source for the generation and detection of anti-
bodies truly specific for hematopoietic progenitors. Purification
by panning is thus a simple, highly efficient technique for the
isolation of fetal liver progenitors, and is a valuable tool for
improving our understanding of the molecular and cellular reg-
ulation of human hematopoiesis.
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